Health Care/Hospital

111 Wins Recognition as Pioneer of New Healthtech

"Growth Champion" Award for "1 Drugstore" SHANGHAI, June 23, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that its online retail pharmacy "1 Drugstore" has won two prestigious industry awards. B...

2019-07-23 21:53 126

Shanghai Concord Medical Cancer Center has Accepted Medical Insurance Settlement from Patients from certain Yangtze River Delta Regions

BEIJING, July 23, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solutions provider and an operator of the network of radiotherapy and diagnostic imaging centers inChina, today announced that...

2019-07-23 18:03 338

Innopresso launches Indiegogo campaign for its touchpad-keyboard Mokibo

SEOUL, South Korea, July 23, 2019 /PRNewswire/ -- Innopresso, a member company of theBorn2Global Centre, successfully launched its smart keyboard "Mokibo" on Indiegogo (https://igg.me/at/mokibo/x#/).   Mokibo is a smart keyboard that combines the functions of a keyboard with t...

2019-07-23 15:30 202

CStone receives approval in China to initiate ivosidenib Phase I bridging registrational study for the treatment of IDH1 mutant relapsed or refractory AML

SUZHOU, China, July 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) announced today that it has received approval from China National Medical Products Administration (NMPA) to initiate a Phase I bridging registrational study of ivosidenib (TIBSOVO) for the treatment of rela...

2019-07-22 12:17 1447

VolitionRx Limited Commences Lung Cancer Clinical Study with Fosun Long March in China

AUSTIN, Texas, July 18, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") has executed a contract under the previously announced Memorandum of Understanding, with Shanghai Fosun Long March Medical Science Co., Ltd. ("Fosun Long March") to help introduce the Nu.Q(TM) platf...

2019-07-18 20:30 4693

Yuyu Pharma Receives Recognition for Outstanding Company Culture in Korea

SEOUL, South Korea, July 17, 2019 /PRNewswire/ -- Yuyu Pharma has received recognition as a Great Place to Work from the mayor of Jechoen city. The company also supported a recent HeForShe movement sponsored by the city of Jechoen. HeforShe is an UN-led gender equality movement that focuses on th...

2019-07-17 21:00 1173

Kazia calls for greater awareness of the deadliest brain cancer in the US

SYDNEY, July 17, 2019 /PRNewswire/ -- This Glioblastoma Awareness Day, Australian oncology-focused biotech company, Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA), calls for greater awareness of the most lethal brain cancer in the US. Glioblastoma (GBM) is the most common, complex, treatment ...

2019-07-17 20:00 5556

AirXpanders® Announces Reduction in Force and Plan to Cease Operations

SAN JOSE, California, July 17, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the Company has reduced its workforce and plans to cease operations. ...

2019-07-17 07:17 5870

AirXpanders® Receives FDA 510(k) Clearance for a Smooth Shell Version of the AeroForm® Tissue Expander System

SAN JOSE, California, July 15, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the company has received U.S. Food and Drug Administration (FDA) 510(k...

2019-07-15 09:17 1155

Yuyu Pharma held the campaign for enhancing corporate transparency

SEOUL, South Korea, July 10, 2019 /PRNewswire/ -- Yuyu Pharma, a Korean pharmaceutical company celebrated its third year of implementing Yuyu's compliance management system by inviting senior management to its "Self-Compliance Day" workshop.

2019-07-11 16:43 1588

MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China

ROCKVILLE, Md. and SHANGHAI, July 10, 2019 /PRNewswire/ -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, and I-Mab Biopharma (I-Mab), aChina and U.S....

2019-07-11 04:01 1584

VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding

AUSTIN, Texas, July 10, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has been awarded additional non-dilutive funding in the form of a non-repayable cash grant totaling approximately$1.4 million from the Walloon Region, Belgium.  To date, Agen...

2019-07-10 20:30 11004

Spectrum Therapeutics partners with Canadian Mental Health Association's Not Myself Today® initiative

SMITHS FALLS, Ontario and TORONTO, July 10, 2019 /PRNewswire/ -- Spectrum Therapeutics ("Spectrum"), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the "Company" or "Canopy Growth") is pleased to announce a partnership with the Canadian Mental Health Association ("CMHA...

2019-07-10 20:00 7353

CStone announces first patient dosed in China with avapritinib in global Phase III clinical trial in advanced GIST

SUZHOU, China, July 9, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that the first patient has been dosed inChina with avapritinib in the ongoing global Phase III VOYAGER clinical trial. This study is designed to evaluate the safety and efficacy of avapritini...

2019-07-10 10:23 6674

Medeon Led and Completed Investments in Panther Orthopedics and Prodeon

TAIPEI, Taiwan, July 8, 2019 /PRNewswire/ -- Medeon Biodesign, Inc. (TPEx: 6499), aTaiwan publicly traded medical device company, is pleased to announce that it recently led and closed two investments, in Panther Orthopedics and Prodeon. Panther Orthopedics is a Silicon Valley startup company pio...

2019-07-08 17:10 12283

iMedX, Inc. Launches Industry Leading Analytics and Business Intelligence with Acquisition of Prevalent, Inc. and Axcension, Inc.

Combined Technology & Teams Will Provide Healthcare Clients Unparalleled Insight into Operations and Billing Functions Existing iMedX Solutions Will Utilize Precision Analytics to Further Increase Efficiency and Boost Cash Flow ATLANTA and KATY, Texas, July 8, 2019 /PRNewswire/ -- iMedX, Inc. (i...

2019-07-08 13:03 1703

New England Biolabs®, Inc. opens eighth subsidiary in Australia

IPSWICH, Massachusetts, July 4, 2019 /PRNewswire/ -- New England Biolabs (NEB® ), a world leader in the production of reagents for the life science industry, extended its global subsidiary network with the opening of New England Biolabs Australia Pty Ltd. Australia's Life Sciences industry is hom...

2019-07-03 22:00 1658

China SXT Pharmaceuticals, Inc. Announces TCM Homologous Supplements Production

TAIZHOU, China, July 3, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces ("TCMPs"), today announced ...

2019-07-03 20:00 15188

Vast Potential of Elderly Care Sector Now Taking Off in China

SHANGHAI, July 2, 2019 /PRNewswire/ -- With China's population aged over 60 surpassing one quarter of a billion this year and set to add a further 10 million to its ranks every year through 2025,CHINA AID, organized by Shanghai Intex Exhibition Co., Ltd., reflects the rising success of elderly ca...

2019-07-02 22:00 1492

CSL Behring Delivers on its Promise to Advance Bleeding Disorder Treatment Research by Supporting 16 Data Presentations at ISTH 2019

Novel real world evidence for AFSTYLA® and IDELVION® to be highlighted MELBOURNE, Australia, July 1, 2019 /PRNewswire/ -- Global biotherapeutics leaderCSL Behring announced today that the company will support the presentation of new data from its recombinant coagulation factor programs at this ...

2019-07-02 06:15 7166
12345 ... 522